Bevacizumab in neoadjuvant chemotherapy increases the pathological complete response rate in patients with triple-negative breast cancer

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Prognostic Function of Ki-67 for Pathological Complete Response Rate of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

Tumori Journal ◽

10.1177/030089161410000204 ◽

2014 ◽

Vol 100 (2) ◽

pp. 136-142 ◽

Cited By ~ 3

Author(s):

Guojing Zhang ◽

Wanqing Xie ◽

Zhaozhe Liu ◽

Chao Lin ◽

Ying Piao ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Ki 67

Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer

Journal of Huazhong University of Science and Technology [Medical Sciences] ◽

10.1007/s11596-013-1108-9 ◽

2013 ◽

Vol 33 (2) ◽

pp. 262-265 ◽

Cited By ~ 4

Author(s):

Yi Yin ◽

Pin Zhang ◽

Bing-he Xu ◽

Bai-lin Zhang ◽

Qing Li ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Locally Advanced ◽

Is Pathological Complete Response Rate Associated with Improved Local Control in Localized Triple Negative Breast Cancer After Neoadjuvant Chemotherapy?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.600 ◽

2017 ◽

Vol 99 (2) ◽

pp. E4

Author(s):

T. Biswas ◽

J.T. Efird ◽

S. Prasad ◽

S.E. James ◽

T.M. Zagar

Keyword(s):

Breast Cancer ◽

Local Control ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer

Annals of Oncology ◽

10.1093/annonc/mdw364.43 ◽

2016 ◽

Vol 27 ◽

pp. vi55 ◽

Cited By ~ 1

Author(s):

M.R. Chica-Parrado ◽

A. Santonja ◽

A. Lluch-Hernandez ◽

J. Albanell ◽

A. Sanchez-Muñoz ◽

...

Keyword(s):

Breast Cancer ◽

Androgen Receptor ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Oncotarget ◽

10.18632/oncotarget.25413 ◽

2018 ◽

Vol 9 (41) ◽

pp. 26406-26416 ◽

Cited By ~ 36

Author(s):

Angela Santonja ◽

Alfonso Sánchez-Muñoz ◽

Ana Lluch ◽

Maria Rosario Chica-Parrado ◽

Joan Albanell ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Pathologic Complete Response ◽

Complete Response ◽

Cancer Subtypes ◽

Pathologic Complete Response Rate

Triple-negative breast cancer subtypes and pathologic complete-response rate to neoadjuvant chemotherapy: Results from the GEICAM/2006-2003 study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.1024 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 1024-1024

Author(s):

Angela Santonja ◽

Joan Albanell ◽

Jose Ignacio Chacon ◽

Ana Lluch ◽

Alfonso Sanchez-Muñoz ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Pathologic Complete Response ◽

Complete Response ◽

Cancer Subtypes ◽

Pathologic Complete Response Rate

Pathological Complete Response Rate (pCR) in Patients with Triple Negative Breast Cancer (TNBC) who Received Either Platinum and Taxane Containing Regimen or Taxane Containing Regimen Alone, Along with Anthracyclines: Real Life Results from South East London Accountable Cancer Network

Clinical Oncology ◽

10.1016/j.clon.2020.02.028 ◽

2020 ◽

Vol 32 (8) ◽

pp. e173-e174

Author(s):

E. Tsotra ◽

R. Hale ◽

N. Yoganayagam ◽

R. Nathan

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Real Life ◽

Complete Response ◽

Cancer Network

Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer

Magnetic Resonance Materials in Physics Biology and Medicine ◽

10.1007/s10334-021-00941-0 ◽

2021 ◽

Author(s):

Angeline Nemeth ◽

Pierre Chaudet ◽

Benjamin Leporq ◽

Pierre-Etienne Heudel ◽

Fanny Barabas ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response To Neoadjuvant Chemotherapy

Complete Response ◽

Abstract P3-11-14: Circulating lymphocytes and pathologic complete response rate among patients with early stage triple negative breast cancer treated with neoadjuvant chemotherapy

10.1158/1538-7445.sabcs18-p3-11-14 ◽

2019 ◽

Author(s):

SM Talamantes ◽

RL Costa ◽

A Rademaker ◽

CA Santa-Maria

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Early Stage ◽

Pathologic Complete Response ◽

Complete Response ◽

Circulating Lymphocytes ◽

Pathologic Complete Response Rate

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy

Oncotarget ◽

10.18632/oncotarget.9369 ◽

2016 ◽

Vol 8 (11) ◽

pp. 18399-18408 ◽

Cited By ~ 1

Author(s):

JunJie Li ◽

Sheng Chen ◽

CanMing Chen ◽

GenHong Di ◽

GuangYu Liu ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Complete Response ◽

Relapse Free Survival ◽

Free Survival